How can I manage anaesthesia in obese patients?


Journal

Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401

Informations de publication

Date de publication:
04 2020
Historique:
received: 30 03 2019
revised: 01 12 2019
accepted: 09 12 2019
pubmed: 19 2 2020
medline: 15 6 2022
entrez: 19 2 2020
Statut: ppublish

Résumé

The obese patient is at risk of perioperative complications including difficult airway access (intubation, difficult or impossible ventilation), and postextubation acute respiratory failure due to the formation of atelectases or to airway obstruction. The association of obstructive sleep apnoea syndrome (OSA) with obesity is very common, and induces a high risk of per and postoperative complications. Preoperative OSA screening is crucial in the obese patient, as well as its specific management: use of continuous positive pre-, per- and postoperative pressure. For any obese patient, the implementation of difficult intubation protocols and the use of protective ventilation (low tidal volume 6-8mL/kg of ideal body weight, moderate positive end-expiratory pressure of 10cmH20, recruitment manoeuvres in absence of contra-indications), with morphine sparing and semi-seated positioning as much as possible are recommended, associated with a close postoperative monitoring. The dosage of anaesthetic drugs is usually based on the ideal body weight or the adjusted body weight and then titrated, except for succinylcholine that is dosed according to the total body weight. Monitoring of neuromuscular blockers should be used where appropriate, as well as monitoring of the depth of anaesthesia, especially when total intravenous anaesthesia is used in association with neuromuscular blockers. The occurrence of intraoperative awareness is indeed more frequent in the obese patient than in the non-obese patient. Appropriate prophylaxis against venous thromboembolism and early mobilisation are recommended, if possible included in an early rehabilitation protocol, to further reduce postoperative complications.

Identifiants

pubmed: 32068132
pii: S2352-5568(20)30022-9
doi: 10.1016/j.accpm.2019.12.009
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

229-238

Informations de copyright

Copyright © 2020 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Audrey De Jong (A)

Inserm, CNRS, PhyMedExp, département d'anesthésie-réanimation, CHU Montpellier, university of Montpellier, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France. Electronic address: audreydejong@hotmail.fr.

Amélie Rollé (A)

Département d'anesthésie-réanimation, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

François-Régis Souche (FR)

Département de chirurgie digestive (A), mini-invasive et oncologique, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

Olfa Yengui (O)

Département d'anesthésie-réanimation, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

Daniel Verzilli (D)

Département d'anesthésie-réanimation, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

Gérald Chanques (G)

Inserm, CNRS, PhyMedExp, département d'anesthésie-réanimation, CHU Montpellier, university of Montpellier, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

David Nocca (D)

Département de chirurgie digestive (A), mini-invasive et oncologique, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

Emmanuel Futier (E)

Département de médecine périopératoire, anesthésie-réanimation, hôpital Estaing, CHU de Clermont-Ferrand, 63000 Clermont-Ferrand, France.

Samir Jaber (S)

Inserm, CNRS, PhyMedExp, département d'anesthésie-réanimation, CHU Montpellier, university of Montpellier, hôpital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH